Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.

被引：6
|
作者：
Grivas, Petros [1 ,2 ]
Barata, Pedro C. [3 ]
Moon, Helen H. [4 ]
Gupta, Shilpa [5 ]
Hutson, Thomas E. [6 ]
Sternberg, Cora N. [7 ]
Brown, Jason [8 ]
Dave, Vaidehi [9 ]
Downey, Chad [10 ]
Shillington, Alicia C. [11 ]
Katzenstein, Howard [12 ]
Kirker, Melissa
Hanson, Sarah
Liu, Frank X.
Morris, Valerie A.
Bhanegaonkar, Abhijeet
Sonpavde, Guru P.
机构：
[1] Univ Washington, Div Hematol & Oncol, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
[3] Univ Hosp Seidman, Canc Ctr, Cleveland, OH USA
[4] Kaiser Permanente, Riverside, CA USA
[5] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[6] Texas Oncol, Dallas, TX USA
[7] Weill Cornell Med, Hematol Oncol, New York, NY USA
[8] RTI Hlth Solut, Res Triangle Pk, NC USA
[9] EPI Q Inc, Oak Brook, IL USA
[10] EMD Serono, Rockland, MA USA
[11] Pfizer, New York, NY USA
[12] AdventHlth Med Grp, Orlando, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-492-3532-2370-7650-2700; 283-183-138-12268; 130-231; 261-492-11294; 261-492-3532-2370; 613-135-244-3829; 5; 4; 3; 2; 1880; 62; 295; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：697 / 697
页数：1
相关论文
共 50 条
  • [31] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [33] J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan
    Kikuchi, Eiji
    Hayakawa, Nozomi
    Nakayama, Masashi
    Uno, Masahiro
    Nakatsu, Hiroomi
    Kitagawa, Chiyoe
    Miyake, Hideaki
    Yamada, Takeshi
    Fujita, Kazutoshi
    Shimoyama, Hideaki
    Nishihara, Kiyoaki
    Kobayashi, Mizuki
    Nakamura, Motonobu
    Fujimoto, Kiyohide
    Sano, Takeshi
    Nishiyama, Naotaka
    Ito, Takayuki
    Kajita, Masahiro
    Kobayashi, Takashi
    Kitamura, Hiroshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (08) : 859 - 867
  • [34] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
  • [35] SPADE: Design of a real-world observational study of avelumab first-line maintenance (1LM) in advanced urothelial carcinoma in the Asia-Pacific region
    Oliveira, Niara
    Su, Po Jung
    Park, Se Hoon
    Tsai, Yu Chieh
    Kim, Miso
    Wu, Wen Jeng
    Gao, Seasea
    Shin, Sang Joon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 97 - 97
  • [36] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [37] Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC)
    Bracarda, Sergio
    Antonuzzo, Lorenzo
    Maruzzo, Marco
    Santini, Daniele
    Tambaro, Rosa
    Buti, Sebastiano
    Carrozza, Francesco
    Calabro, Fabio
    Di Lorenzo, Giuseppe
    Fornarini, Giuseppe
    Iacovelli, Roberto
    Cullura, Daniela
    Messina, Carlo
    Cerbone, Linda
    Fazzi, Gennaro
    Venturini, Filippo
    Colasanto, Raffaele
    Necchi, Andrea
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 558 - 558
  • [38] Real-world (rw) treatment (tx) patterns, sequencing, and outcomes in US patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with avelumab first-line maintenance (1LM)
    Carson, Kenneth Robert
    Ike, Chiemeka
    Mahmoudpour, Seyed Hamidreza
    Monzon, Sebastian
    Fragkogianni, Stamatina
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] PATRIOT II: An ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States.
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen
    Hutson, Thomas E.
    Gupta, Shilpa
    Sternberg, Cora N.
    Pickard, A. Simon
    Dave, Vaidehi
    Han, Natalia
    Shillington, Alicia C.
    Devgan, Geeta
    Kim, Ruth
    Thakkar, Sheena
    Katzenstein, Howard
    Bhanegaonkar, Abhijeet
    Liu, Frank
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Kim, Sandra
    Ma, Josh
    Eigl, Bernie
    Alimohamed, Nimira
    Kulkarni, Girish
    Chung, Peter
    Graham, Jeffrey
    Breau, Rodney
    Ong, Michael
    Levesque, Eric
    Basappa, Naveen
    Rendon, Ricardo
    Castilloux, Jean
    Winquist, Eric
    Siemens, Robert
    Lattouf, Jean-Baptiste
    Mukherjee, Som
    Yokom, Daniel
    Kassouf, Wassim
    Black, Peter
    JOURNAL OF UROLOGY, 2024, 211 (05): : E863 - E863
12345